Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 1 Sept 2009 |
| Operating profit growth of 7% in the first half of 2009 | 13 Aug 2009 |
| Novozymes A/S, Group financial statement for first quarter of 2009 | 29 Apr 2009 |
| Updated Company calendar 2009 | 10 Mar 2009 |
| Annul Shareholders' Meeting 2009 | 5 Mar 2009 |